The 50 Most-Frequently Cited Articles in Neuro Oncol

QUICK SEARCH:

	Author:		Keyword(s):
Year:		Vol:		Page:

The 50 Most-Frequently Cited Articles
in Neuro Oncol as of November 1, 2008 -- updated monthly

Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.

6. Caterina Giannini, Jann N. Sarkaria, Atsushi Saito, Joon H. Uhm, Evanthia Galanis, Brett L. Carlson, Mark A. Schroeder, C. David James
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
NEURO ONCOL Apr 01, 2005; 7: 164-176.
(In "Molecular Genetics")   [Abstract]     [PDF]

7. Kenneth R. Hess, Eric T. Wong, Kurt A. Jaeckle, Athanassios P. Kyritsis, Victor A. Levin, Michael D. Prados, W. K. Alfred Yung
Response and progression in recurrent malignant glioma
NEURO ONCOL Oct 01, 1999; 1: 282-288.
(In "Clinical Therapy Trials - Outcome")   [Abstract]     [PDF]

8. Tanya S. Surawicz, Bridget J. McCarthy, Varant Kupelian, Patti J. Jukich, Janet M. Bruner, Faith G. Davis, the collaborating registries of the Central Brain Tumor Registry of the United States
Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994
NEURO ONCOL Jan 01, 1999; 1: 14-25.
(In "Epidemiology and Cancer Control")   [Abstract]     [PDF]

9. Dennis R. Groothuis
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
NEURO ONCOL Jan 01, 2000; 2: 45-59.
(In "Review Article")   [Abstract]     [PDF]

10. Michael D. Prados, Kathleen R. Lamborn, Susan Chang, Eric Burton, Nicholas Butowski, Mary Malec, Ami Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
NEURO ONCOL Jan 01, 2006; 8: 67-78.
(In "Clinical Therapy Trials—Drug")   [Abstract]     [Full Text]     [PDF]

[Previous 5 Articles]    [Next 5 Articles]

= from the current issue

Last Updated: 11/07/2008 19:01:28

6.	Caterina Giannini, Jann N. Sarkaria, Atsushi Saito, Joon H. Uhm, Evanthia Galanis, Brett L. Carlson, Mark A. Schroeder, C. David James
		Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
		NEURO ONCOL Apr 01, 2005; 7: 164-176. (In "Molecular Genetics") [Abstract] [PDF]


7.	Kenneth R. Hess, Eric T. Wong, Kurt A. Jaeckle, Athanassios P. Kyritsis, Victor A. Levin, Michael D. Prados, W. K. Alfred Yung
		Response and progression in recurrent malignant glioma
		NEURO ONCOL Oct 01, 1999; 1: 282-288. (In "Clinical Therapy Trials - Outcome") [Abstract] [PDF]


8.	Tanya S. Surawicz, Bridget J. McCarthy, Varant Kupelian, Patti J. Jukich, Janet M. Bruner, Faith G. Davis, the collaborating registries of the Central Brain Tumor Registry of the United States
		Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994
		NEURO ONCOL Jan 01, 1999; 1: 14-25. (In "Epidemiology and Cancer Control") [Abstract] [PDF]


9.	Dennis R. Groothuis
		The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery
		NEURO ONCOL Jan 01, 2000; 2: 45-59. (In "Review Article") [Abstract] [PDF]


10.	Michael D. Prados, Kathleen R. Lamborn, Susan Chang, Eric Burton, Nicholas Butowski, Mary Malec, Ami Kapadia, Jane Rabbitt, Margaretta S. Page, Ann Fedoroff, Dong Xie, Sean K. Kelley
		Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
		NEURO ONCOL Jan 01, 2006; 8: 67-78. (In "Clinical Therapy Trials—Drug") [Abstract] [Full Text] [PDF]


[Previous 5 Articles] [Next 5 Articles]